The swabs collection kit market is expected to grow from US$ 4,141.32 million in 2021 to US$ 5,641.68 million by 2028; it is estimated to register a CAGR of 4.5% from 2021 to 2028.

The growth of the swabs collection kit market is mainly attributed to factors such as the rising number of COVID-19 cases and increasing demand for accurate and modern swabs collection kits. However, the lack of skilled professionals and limitations of swabs collection kits hinder the market growth.

The swab collection kit is one of the important tools used among medical devices technologies such as vitals and reagents, to collect samples for the laboratory, where the testing services will be performed on such a sample. The high demand for sample collection kits, owing to the COVID-19 pandemic, and approval of new & advanced detection tests by authorities are the key factors that are expected to drive the market. Continuous R&D activities, significant investments, and focus on the development of reagents and kits formulations for sample detection and testing are anticipated to fuel the market growth. Moreover, various players and government initiatives have developed integrated platforms to increase the functionality of diagnostic analysis and sensing. For instance, in May 2020, The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Everlywell, Inc. for the COVID-19 Test Home Collection Kit. The product is a standalone, at-home nasal swab sample collection kit that can be sent to specified labs for subsequent COVID-19 diagnostic testing. Nasopharyngeal sampling is considered safe, despite adjacent vital structures. The increasing number of investments, launches, and collaborations is playing a vital role in the development of advanced diagnostic kits. For instance, in February 2020, Covaris, Inc. announced the release of two new kits for viral RNA extraction from nasal or throat swab sample collection devices. The first is the truXTRAC Viral RNA Extraction kit using Puritan Swabs, which contains all components for AFA-enhanced extraction and magnetic bead-based purification of high-quality RNA from synthetic swabs for downstream analysis. The potential of swab collection kits in at-home kits is also being accepted by the healthcare professionals during the unprecedented times of the COVID-19 pandemic, which represents the superiority of this technology over other techniques for reducing the risk of transmitting the virus. During the COVID-19 pandemic, numerous swab samples have been taken for SARS-CoV-2 reverse transcriptase-polymerase chain reaction (RT-PCR) testing.

The global swabs collection kit market is segmented into type and application. Based on type, the swabs collection kit market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs held the largest share of the market in 2021, whereas the oropharyngeal swabs segment is anticipated to register the highest CAGR in the market during the forecast period. Based on application, the swabs collection kit market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment is likely to hold the largest share of the market in 2021, whereas the diagnostic laboratories segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the microbial air sampler market are the World Health Organization (WHO), Association of Indian Medical Device Industry (AiMeD), Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (US FDA).